Who We Are

BioMarin is a global biotechnology company that relentlessly pursues bold science to translate genetic discoveries into new medicines that advance the future of human health.

Since our founding in 1997, we have applied our scientific expertise in understanding the underlying causes of genetic conditions to create transformative medicines, using a number of treatment modalities.

Using our unparalleled expertise in genetics and molecular biology, we develop medicines for patients with significant unmet medical need. We enlist the best of the best – people with the right technical expertise and a relentless drive to solve real problems – and create an environment that empowers our teams to pursue bold, innovative science. With this distinctive approach to drug discovery, we’ve produced a diverse pipeline of commercial, clinical and preclinical candidates that have well-understood biology and provide an opportunity to be first-to-market or offer a substantial benefit over existing therapeutic options.

SUMMARY DESCRIPTION

• Plan, develop, and disseminate HEOR evidence to demonstrate the value of BioMarin’s assets.
• Actively influence and shape evidence generation delivered by cross-functional partners (i.e. Clinical Sciences, Medical Affairs) to ensure that they meet the needs of Market Access.
• Be an acknowledged subject matter expert supporting country and regional market access leads with evidence communication to external stakeholders including payers and health technology assessment (HTA) agencies.

• Lead the global compound access evidence plan in support of the access strategy.
• Provide the market access voice in global cross-functional evidence forums including the Value & Access Team and the Integrated Evidence Team.
• Become a subject matter expert in value demonstration methods and communication.

• Lead HEOR evidence generation, synthesis and dissemination.
• Project manage vendors to deliver high quality deliverables on time and on budget.
• Review and influence clinical and medical activities including trial design, endpoints and analytical approaches to ensure they meet payer needs.
• Lead secondary analyses of clinical data to address market access needs.

• Interpret and communicate evidence to internal stakeholders including country and regional market access teams and cross-functional partners.
• Support country access teams with adaptation of materials and review/sign-off of reimbursement submissions.
• Represent BioMarin at external meetings with payers and HTA agencies as required.

• 7+ years of HEOR experience obtained within the pharmaceutical industry.
• Demonstrated ability to deliver a range of HEOR evidence projects including cost-effectiveness models, budget impact models, systematic literature reviews and real-world data analysis.
• History of working cross functionally, influencing, and gaining alignment across Market Access, Commercial, Medical, Clinical and Regulatory departments.

• Comfortable interacting with external decision makers, health economists, clinical experts and patient organizations. 
• Sound knowledge and experience of different payer architypes and appreciation for the broader market access environment – global or multi-country experience preferred. 
• Excellent verbal and written communication, collaboration, influence, strategic, analytical and problem-solving skills are required.
• Working knowledge of common statistical packages and reference management software preferred.

EDUCATION

• Postgraduate qualifications (Masters or PhD) in public health, health economics, epidemiology or statistics

Note: This description is not intended to be all-inclusive, or a limitation of the duties of the position. It is intended to describe the general nature of the job that may include other duties as assumed or assigned.

Equal Opportunity Employer/Veterans/Disabled

An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.